Shares of Sequenom (SQNM +9.5%) pop after the firm raises its estimate for billings for...
Shares of Sequenom (SQNM +9.5%) pop after the firm raises its estimate for billings for MaterniT21 in 2012 to 40K from a previous forecast of 25K. The firm says it will increase internal production goals based on the improved outlook.
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs